III/IV) gastric cancer than in those with early (stage I/II) cancer. Stratification by location, Lauren's classification and histological differentiation revealed no significant differences in genotype distribution. Thus, in this Chinese population the KLF6 IVS1 −27AA genotype was associated with a decreased risk of gastric cancer and with cancer stage. Further study is required to clarify the mechanisms involved and, potentially, to facilitate the design of effective clinical trials.
Association
of the IVS1 −27G/A polymorphism of Krüppel-like factor 6 (KLF6) with gastric cancer was examined in a Chinese population comprising 300 gastric cancer patients and 300 healthy controls.
Single-nucleotide polymorphism analysis was performed by amplifying intron 1 of KLF6 and sequencing the products. The KLF6 genotype IVS1 −27AA was significantly less frequent in gastric cancer patients than in controls and significantly less frequent in patients with advanced (stage Introduction Gastric cancer is the second most frequent cause of death from cancer throughout the world and is, therefore, an important health problem. 1 Of cases worldwide, 38% occur in China where it remains the most common cancer in both sexes, as it is elsewhere in eastern Asia. 2 A major strategy for dealing with this healthcare problem is the identification of individuals at risk, improvement of which will contribute to the prevention and early detection of the disease. Knowledge about the molecular alterations involved in the genesis of gastric cancer may lead to new and more effective means for controlling this lethal disease.
The last decade has seen increasing interest in the role of genetic polymorphisms in gastric cancer. 3 -5 Krüppel-like factor 6 (KLF6) belongs to the Krüppel-like family of transcription factors which are known to play diverse roles in differentiation, *H Chen and L Chen contributed equally to this work and are joint first authors. H Chen, L Chen, QF Zhang KLF6 polymorphism and gastric cancers in Chinese development, cell growth, apoptosis and angiogenesis; 6 -8 KLF6 itself is a ubiquitously expressed zinc finger transcription factor. 9, 10 The gene, KLF6, is a tumour suppressor and is inactivated by allelic loss and somatic mutation in several human cancers, 11 -13 including hepatocellular carcinoma and prostate, gastric and colon cancers. 14 -22 A functional single-nucleotide polymorphism (SNP) in the KLF6 gene has been identified recently; KLF6 IVS1 −27G/A (rs3750861) is located within the first intron of the gene and is associated with increased incidences of familial prostate and lung cancers. 23, 24 This polymorphism generates a novel functional DNA binding site for the splicing factor serine/arginine-rich protein 40 (SRp40) and increases the transcription of three alternatively spliced KLF6 isoforms which antagonize the tumour suppressor function of wild-type KLF6. 25 -27 A recent report has suggested that the KLF6 IVS1 −27G/A polymorphism is not associated with an increased risk of gastric cancer in a Korean population. 28 Here we conducted a case-control study to investigate whether the KLF6 IVS1 −27G/A polymorphism is associated with gastric cancer in a Chinese population.
Patients and methods

STUDY PARTICIPANTS
All subjects were selected from a hospitalbased case-control study performed at the Department of General Surgery of the Fourth Affiliated Hospital of Harbin Medical University, Harbin, China, between 2008 and 2010. The study included patients for whom serum samples were available for DNA extraction and controls with no evidence of gastric cancer. All gastric cancers were pathologically confirmed as stomach adenocarcinomas. The healthy control population was from the same geographical region as the cancer patients.
Informed consent was obtained from all subjects according to the Declaration of Helsinki, 1996, and the study was approved by the Institutional Review Board of Harbin Medical University.
GENOTYPING
Genomic DNA was extracted from blood samples using a commercial kit (QIAamp ® ; Qiagen, Valencia, CA, USA). The IVS1 −27G/A polymorphism of KLF6 was analysed by polymerase chain reaction (PCR)restriction fragment length polymorphism. The PCR conditions for KLF6 IVS1 −27 genotyping were: 95°C for 2 min, 95°C for 10 min, then 40 cycles of 95°C for 15 s and, finally, 60°C for 1 min. The PCR products were digested with 5 U of the restriction enzyme BsaAI (New England Biolabs, Beverly, MA, USA) at 37°C for 16 h. DNA fragments then were electrophoresed on a 12% polyacrylamide gel. The PCR primer sequences were: sense 5′-CCGGGCAGCA ATGTTATC-3′; antisense 5′-TTTGGTCCACAG ATCTTCCTG-3′.
STATISTICAL ANALYSES
Genotype frequencies of KLF6 IVS1 −27 were compared between gastric cancer patients and controls using the χ 2 -test. Crude odds ratios (ORs) and ORs adjusted for sex and age with 95% confidence intervals (CI) were calculated by logistic regression analysis. A P-value < 0.05 was considered statistically significant. All statistical tests were twosided. Evidence for deviation from Hardy-Weinberg equilibrium of alleles at individual loci was assessed by exact tests using the program GENEPOP. 29 Stata ® version 8.0 (Stata Corp., College Station, TX, USA) was used to perform all the statistical analyses.
Results
The study included 300 patients with gastric Table  1 . Cases and controls did not differ significantly regarding gender, age or height, however there were significant differences in weight (P = 0.004), smoking (P = 0.02) and alcoholic drink status (P = 0.02).
Allele distribution for the KLF6 IVS1 −27 polymorphism did not deviate from Hardy-Weinberg equilibrium either in the controls or in the gastric cancer patients. The KLF6 IVS1 −27 AA genotype was significantly less frequent in gastric cancer patients (OR 0.41; 95% CI 0.17, 0.94; P = 0.04) compared with controls ( Table 2) . When patients were stratified according to the stage of gastric cancer, patients with advanced gastric cancer (stage III or IV) were found to have a significantly lower frequency of genotype AA than those with early (stage I/II) gastric cancer (OR 0.09; 95% CI 0.01, 0.72; P = 0.02) ( Table 3) . Stratification by location, Lauren's classification or histological differentiation of gastric cancer revealed no significant differences in genotype distribution ( Table 3 ).
Discussion
The results of this study indicated that the H Chen, L Chen, QF Zhang KLF6 polymorphism and gastric cancers in Chinese KLF6 IVS1 −27 AA genotype was associated with a decreased risk of gastric cancer in this Chinese population and that patients with advanced gastric cancer (stage III or IV) had a significantly lower frequency of the AA genotype than those with early gastric cancer (stage I or II). KLF6 is a key cell cycle regulator and is down-regulated in several kinds of human cancer, 12, 28, 30, 31 including gastric cancer. Although the present study found that the IVS1 −27G/A polymorphism of KLF6 influenced susceptibility to gastric cancer and disease outcome in a Chinese population, Cho et al. 28 recently suggested that this polymorphism was not associated with an increased risk of gastric cancer in a Korean population.
The KLF6 IVS1 −27G/A polymorphism has been studied in several human cancers. For example, Narla et al. 27 reported that a single intronic SNP of the KLF6 gene results in increased production of splice variants, which functionally antagonize the growthsuppressive properties of wild-type KLF6 by affecting the level of the cyclin-dependent kinase inhibitor p21. In addition, the IVS1 −27G/A SNP of KLF6 was shown to be associated with familial and sporadic prostatic cancers. 27 However, an association between the polymorphism and increased risk of prostate cancer was not found in Ashkenazi Jewish and Finnish populations. 15, 16 Spinola et al. 23 demonstrated the potential involvement of KLF6 polymorphisms in the risk of lung cancer. Moreover, Miele et al. 32 reported that the KLF6 IVS1 −27G/A polymorphism is associated with advanced non-alcoholic fatty liver disease.
The association found in the present study between the KLF6 IVS1 −27AA genotype and gastric cancer was unlikely to be due to type I error. The allele distribution of the polymorphism did not deviate from Hardy-Weinberg equilibrium either for the controls or for the gastric cancer patients and this is consistent with previous reports on other cancers. 33 -35 Nevertheless, as is true of all genetic association studies, the present findings will need to be confirmed in other populations.
The present study has some limitations. First, these results should be interpreted with caution because the population studied was from China; although this reduces the possibility of confounding because of ethnicity, it does not permit extrapolation of the results to other ethnic groups. Secondly, the study was based on unadjusted estimates. Finally, further study is required to delineate the precise mechanisms involved and, potentially, to facilitate the design of effective clinical trials.
In conclusion, the present study demonstrated that the AA genotype of the KLF6 IVS1 −27 polymorphism was associated with a decreased risk of gastric cancer in a Chinese population. Patients with advanced gastric cancer (stage III or IV) had a significantly (P = 0.02) lower frequency of the AA genotype than patients with early gastric cancer (stage I or II). Additional studies in large series are needed to confirm these findings.
